StockData
Mereo BioPharma Group plc logo

Mereo BioPharma Group plc (MREO) stock

MREONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 1/30
$0.29+0.01 (+5.39%)

Close on Nov 18, 2026Market cap $46.20MP/E –Yield –

Mereo BioPharma enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Mereo BioPharma's enterprise value was $19.03M on Nov 11, 2026, against $246.64M a year earlier. Over the last 5 years it ranged from $1.80M to $582.12M, with a median of $124.38M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$19.03M+11.2%
2025Dec 31, 2025$17.11M-96.1%
2024Dec 31, 2024$434.04M+106.2%
2023Dec 29, 2023$210.49M+152.7%
2022Dec 30, 2022$83.29M-23.2%
2021Dec 31, 2021$108.47M+69.4%
2020Dec 31, 2020$64.03M-99.9%
2019Dec 31, 2019$46.67B+33813324.8%
2018Apr 25, 2018$138.03K+54.1%
2017Apr 28, 2017$89.58K–

More Mereo BioPharma figures

See a number that looks wrong?